-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Plus Therapeutics, Lowers Price Target to $3

Benzinga·06/27/2025 11:56:01
Listen to the news
HC Wainwright & Co. analyst Sean Lee maintains Plus Therapeutics (NASDAQ:PSTV) with a Buy and lowers the price target from $5.5 to $3.